HIGHLIGHTS
- who: Carl-Jacob Holmberg et al. from the DepartmentSahlgrenska University have published the research: Effects of the , in the Journal: Cancers 2023, 15, x FOR PEER REVIEW of /2023/
- what: The aims of this study were to compare the characteristics of the patient population receiving ILP before and after the introduction of modern systemic treatments and to assess if outcomes after ILP were influenced by previous immunotherapy treatment. The authors report an ORR of 84% and a CR rate of 52%, which is comparable to previously established response rates for ILP . The main limitations of . . .
If you want to have access to all the content you need to log in!
Thanks :)
If you don't have an account, you can create one here.